19190908

Source:http://linkedlifedata.com/resource/pubmed/id/19190908

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024623, umls-concept:C0030705, umls-concept:C0069717, umls-concept:C0205179, umls-concept:C0246415, umls-concept:C0879262, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	2009-8-18
pubmed:abstractText	To determine the maximum tolerated dose (MTD), recommended dose (RD), and activity of combined docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy on metastatic gastric cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1432-0843
pubmed:author	pubmed-author:HanTaehoT, pubmed-author:HwangSe WonSW, pubmed-author:JangKyung MiKM, pubmed-author:JungJoo YoungJY, pubmed-author:KimHo YoungHY, pubmed-author:KimHyeong SuHS, pubmed-author:KimHyo JungHJ, pubmed-author:KimJung HanJH, pubmed-author:KimMin-JeongMJ, pubmed-author:KwonJung HyeJH, pubmed-author:ParkSarahS, pubmed-author:SongHun HoHH, pubmed-author:YangDae HyunDH, pubmed-author:YooKyo-SangKS, pubmed-author:ZangDae YoungDY
pubmed:issnType	Electronic
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	877-83
pubmed:meshHeading	pubmed-meshheading:19190908-Adult, pubmed-meshheading:19190908-Aged, pubmed-meshheading:19190908-Antineoplastic Agents, pubmed-meshheading:19190908-Antineoplastic Agents, Phytogenic, pubmed-meshheading:19190908-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19190908-Dose-Response Relationship, Drug, pubmed-meshheading:19190908-Drug Combinations, pubmed-meshheading:19190908-Female, pubmed-meshheading:19190908-Gastrectomy, pubmed-meshheading:19190908-Humans, pubmed-meshheading:19190908-Male, pubmed-meshheading:19190908-Maximum Tolerated Dose, pubmed-meshheading:19190908-Middle Aged, pubmed-meshheading:19190908-Neutropenia, pubmed-meshheading:19190908-Organoplatinum Compounds, pubmed-meshheading:19190908-Oxonic Acid, pubmed-meshheading:19190908-Stomach Neoplasms, pubmed-meshheading:19190908-Taxoids, pubmed-meshheading:19190908-Tegafur
pubmed:year	2009
pubmed:articleTitle	Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.
pubmed:affiliation	Department of Internal Medicine, Hallym University Medical Center and Hallym University College of Medicine, Anyang, South Korea. fhdzang@hallym.or.kr
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't